Lonza
Listed as Lonza Group
Forbes Global 2000 1897 #1275 by revenue Switzerland Healthcare Drugs & Biotechnology lonza.com
Lonza Group AG engages in the supply of pharmaceutical, healthcare, and life science products.
Forbes Global 2000's description, shown to identify the company. We rate the name, not the business.
- Evocativity EVOC : red
- Place name gives no pharmaceutical cue
- Brevity BREV : green
- 5 letters, 2 syllables. Up to seven letters is green, eight at two syllables too; up to ten yellow, eleven or more red.
- Greppability GREP : green
- Found inside 0 other dictionary words.
- Googlability GOOG : yellow
- Minor Swiss geographic uses compete
- Pronounceability PRON : green
- Lon-za reads regularly
- Spellability SPEL : yellow
- Lonza vowel spelling needs familiarity
- Verbability VERB : red
- No natural pharmaceutical action
- Nominology
- 70
- All seven dimensions and .com ownership, weighted as set out on Methodology.
- Fluency
- 100
- Brevity and pronounceability only: the subset with published outcome evidence behind it.
- PG grade
- 3 / 4
- Graham's own four-step ladder.
- Exact .com
- Owned
- Shape
- invented
- Length
- 5 chars, 2 syllables
- Distinctiveness
- arbitrary
This row is stitched from more than one source. Forbes Global 2000 supplied the company; domain filled brand_name.
Rubric version 2026.10.20-1, judged by gpt-6.1-sol (agent).
This scores the name only. See Methodology.
These judged dimensions came from an AI agent working through the judging queue in a chat, on the same rubric the scoring pipeline sends. The agent passed the calibration exam before its work was accepted, and each batch it judged hid two names with known answers as a check. The model is named as the agent reported it.